ホーム › 非小細胞肺癌 › フロリダ州 › Cape Coral
Cape Coral、FLにおける非小細胞肺癌の臨床試験
Cape Coralとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Regional Cancer Center-Lee Memorial Health System, Fort Myers · 8マイル先
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
被験者募集中第3相
- Florida Cancer Specialists & Research Institute - South, Fort Myers · 8マイル先
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Florida Cancer Specialists, Cape Coral
- Florida Cancer Specialists - South, Fort Myers · 8マイル先
- Florida Cancer Specialists, Fort Myers · 8マイル先
- 他2件
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Florida Cancer Specialists, Fort Myers · 8マイル先
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
被験者募集中第3相
- Florida Cancer Specialists - South, Fort Myers · 8マイル先
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
被験者募集中第2/3相
- Local Institution - 007-922-E, Cape Coral
- SCRI - Florida Cancer Specialists - South Region Research Office, Fort Myers · 8マイル先
- Local Institution - 007-922-B, Fort Myers · 8マイル先
- 他2件
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
被験者募集中第1/2相
- Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers · 8マイル先
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第3相
- Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers · 8マイル先
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
被験者募集中第3相
- Research Site, Fort Myers · 8マイル先
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
被験者募集中第1/2相
- USOR Florida Cancer Specialists South, Fort Myers · 8マイル先
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
被験者募集中第1相
- American Oncology Partners, PA. a Florida professional service corporation, d/b/a Vista Oncology, Fort Myers · 8マイル先
- Florida Cancer Specialists & Research Institute, LLC, Fort Myers · 8マイル先
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
被験者募集中第1/2相
- Florida Cancer Specialists & Research Institute, LLC, Fort Myers · 8マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Cape Coralにおける他の研究
- 大腸癌10件の研究
- 乳がん10件の研究
- アルツハイマー病9件の研究
- がん（全種類）7件の研究
- 子宮内膜がん7件の研究
- 卵巣がん7件の研究
- 脂肪肝6件の研究
- 急性骨髄性白血病6件の研究
- 胃癌5件の研究
- 肥満症5件の研究
- 転移性癌5件の研究
- 肺がん5件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。